Intra Cellular Therapies shares owned by Van Hulzen Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Van Hulzen Asset Management
from 13F filings
Historical chart of Van Hulzen Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Van Hulzen Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Van Hulzen Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $367k | 5.3k | 69.25 |
| 2023-12-31 | $408k | 5.7k | 71.58 |
| 2023-09-30 | $313k | 6.0k | 52.17 |
| 2023-06-30 | $380k | 6.0k | 63.33 |
| 2023-03-31 | $347k | 6.4k | 54.22 |
| 2022-12-31 | $339k | 6.4k | 52.97 |
| 2022-09-30 | $298k | 6.4k | 46.56 |
| 2022-06-30 | $365k | 6.4k | 57.03 |
| 2022-03-31 | $404k | 6.6k | 61.21 |
| 2021-12-31 | $372k | 7.1k | 52.39 |
| 2021-09-30 | $265k | 7.1k | 37.32 |
| 2021-06-30 | $367k | 9.0k | 40.78 |
| 2021-03-31 | $333k | 9.8k | 33.98 |
| 2020-12-31 | $350k | 11k | 31.82 |
| 2020-09-30 | $277k | 11k | 25.65 |
| 2020-06-30 | $272k | 11k | 25.66 |
More positions owned by Van Hulzen Asset Management
View all positions for Van Hulzen Asset Management